Live Breaking News & Updates on Ci 210

Stay updated with breaking news from Ci 210. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SciSparc Shares Rise On Initiating Clinical Trial Of SCI-210

SciSparc Ltd. (SPRC) shares surged by 51% on Friday following the announcement of the initiation of a clinical trial at Soroka Medical Center in Israel. The trial will be conducted using the company's proprietary therapy, SCI-210, which is aimed at easing the symptoms of autism spectrum disorder (ASD) in children. ....

Oz Adler , Soroka Medical Center , Scisparc Ltd , National Autism Research Center , Chief Executive Officer , Ci 210 ,